Live attenuated SIV vaccines are not effective in a postexposure vaccination model
- PMID: 9135877
- DOI: 10.1089/aid.1997.13.593
Live attenuated SIV vaccines are not effective in a postexposure vaccination model
Abstract
Live attenuated simian immunodeficiency virus (SIV) vaccines, like nef deletion mutants, have been the most effective vaccines tested in the SIV/macaque model so far. The efficacy of live attenuated SIV vaccines in therapeutic vaccination and postexposure prophylaxis has not been determined. Inoculation of macaques with a pathogenic challenge virus and an attenuated SIV vaccine at the same time mimics postexposure vaccination, whereby vaccination with the attenuated virus is performed as rapidly as possible after exposure to pathogenic SIV. In the study presented here, four rhesus macaques were coinfected with pathogenic SIV and a nearly 3000-fold excess of a nef deletion mutant of SIV. Four macaques received pathogenic SIV and an approximately 200-fold excess of a nef deletion mutant expressing interleukin 2 (IL-2). The IL-2-expressing SIV had been previously constructed to enhance the immunogenicity of live attenuated SIV vaccines. All coinfected macaques had a high viral load, and some of them developed AIDS-like symptoms and pathological alterations rapidly. In the presence of pathogenic SIV, both live attenuated SIV vaccines did not protect from disease in this postexposure vaccination model.
Similar articles
-
Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus.J Gen Virol. 1996 Dec;77 ( Pt 12):2969-81. doi: 10.1099/0022-1317-77-12-2969. J Gen Virol. 1996. PMID: 9000087
-
Pathogenic conversion of live attenuated simian immunodeficiency virus vaccines is associated with expression of truncated Nef.J Virol. 2000 Feb;74(4):2038-45. doi: 10.1128/jvi.74.4.2038-2045.2000. J Virol. 2000. PMID: 10644378 Free PMC article.
-
Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.J Virol. 1998 Sep;72(9):7501-9. doi: 10.1128/JVI.72.9.7501-7509.1998. J Virol. 1998. PMID: 9696847 Free PMC article.
-
Antiviral CD8+ T cells in the genital tract control viral replication and delay progression to AIDS after vaginal SIV challenge in rhesus macaques immunized with virulence attenuated SHIV 89.6.J Intern Med. 2009 Jan;265(1):67-77. doi: 10.1111/j.1365-2796.2008.02051.x. J Intern Med. 2009. PMID: 19093961 Free PMC article. Review.
-
Protective immunity induced by live attenuated simian immunodeficiency virus.Curr Opin Immunol. 1998 Aug;10(4):436-43. doi: 10.1016/s0952-7915(98)80118-0. Curr Opin Immunol. 1998. PMID: 9722920 Review.
Cited by
-
The human immunodeficiency virus type 1 nef gene can to a large extent replace simian immunodeficiency virus nef in vivo.J Virol. 1999 Oct;73(10):8371-83. doi: 10.1128/JVI.73.10.8371-8383.1999. J Virol. 1999. PMID: 10482588 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical